Evolent Health (EVH) Short term Debt (2020 - 2025)

Evolent Health (EVH) posted quarterly Short term Debt of $5.1 million for Q3 2025, down 97.03% quarter-over-quarter from $172.1 million in Q2 2025.

Evolent Health (EVH) Short term Debt (2020 - 2025) Analysis & Trends

Evolent Health's Short term Debt history runs 5 years deep, the most recent figure standing at $5.1 million for Q3 2025.

In Q3 2025, Short term Debt changed N/A year-over-year to $5.1 million; the TTM figure through Sep 2025 stood at $5.1 million (changed N/A YoY), while the FY2024 annual figure was $171.5 million, changed N/A from the prior year.
Short term Debt for Q3 2025 stood at $5.1 million, down from $172.1 million in the prior quarter.
The five-year high for Short term Debt was $172.1 million in Q2 2025, with the low at $991000.0 in Q3 2023.
The 4-year median for Short term Debt is $26.7 million (2021), against an average of $75.2 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	Evolent Health	529.12 Mn	387.65 Mn	80.84 Mn

Download Data